522 related articles for article (PubMed ID: 25809541)
1. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
Viganò M; Bhoori S; Lampertico P; Donato MF; Iavarone M; Grossi G; Facciorusso A; Caccamo L; Rossi G; Colombo M; Mazzaferro V
Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
3. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
4. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK; Choi JY
J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
Lee S; Kwon CH; Moon HH; Kim TS; Roh Y; Song S; Shin M; Kim JM; Park JB; Kim SJ; Joh JW; Lee SK
Clin Transplant; 2013; 27(5):E597-604. PubMed ID: 24093615
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
Burra P; Germani G; Adam R; Karam V; Marzano A; Lampertico P; Salizzoni M; Filipponi F; Klempnauer JL; Castaing D; Kilic M; Carlis LD; Neuhaus P; Yilmaz S; Paul A; Pinna AD; Burroughs AK; Russo FP
J Hepatol; 2013 Feb; 58(2):287-96. PubMed ID: 23099188
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
Vatansever S; Farajov R; Yılmaz HC; Zeytunlu M; Paköz ZB; Kılıç M
Turk J Gastroenterol; 2019 Jan; 30(1):75-80. PubMed ID: 30644364
[TBL] [Abstract][Full Text] [Related]
9. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hepatitis B following recurrence of hepatocellular carcinoma after living donor liver transplantation.
Ijichi H; Yoshizumi T; Ikegami T; Soejima Y; Ikeda T; Kawanaka H; Uchiyama H; Yamashita Y; Morita M; Oki E; Mimori K; Sugimachi K; Saeki H; Watanabe M; Shirabe K; Maehara Y
Fukuoka Igaku Zasshi; 2013 Oct; 104(10):376-82. PubMed ID: 24511669
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
Campsen J; Zimmerman M; Trotter J; Hong J; Freise C; Brown R; Cameron A; Ghobrial M; Kam I; Busuttil R; Saab S; Holt C; Emond J; Stiles J; Lukose T; Chang M; Klintmalm G
Liver Transpl; 2013 Sep; 19(9):1020-9. PubMed ID: 23852663
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
14. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
15. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
16. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
18. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
19. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
[TBL] [Abstract][Full Text] [Related]
20. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]